{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:49:54Z","timestamp":1785527394726,"version":"3.56.0"},"reference-count":54,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Neurocysticercosis (NCC) is the most common single cause of seizures\/epilepsy in India and several other endemic countries throughout the world. It is also the most common parasitic disease of the brain caused by the cestode <jats:italic toggle=\"yes\">Taenia solium<\/jats:italic> or pork tapeworm. The diagnosis of NCC and the tapeworm carrier (taeniasis) can be relatively inaccessible and expensive for most of the patients. In spite of the introduction of several new immunological tests, neuroimaging remains the main diagnostic test for NCC. The treatment of NCC is also mired in controversy although, there is emerging evidence that albendazole (a cysticidal drug) may be beneficial for patients by reducing the number of seizures and hastening the resolution of live cysts. Currently, there are several diagnostic and management issues which remain unresolved. This review will highlight some of these issues.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/0971-5916.198686","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T07:49:15Z","timestamp":1484898555000},"page":"319-326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":52,"title":["Neurocysticercosis"],"prefix":"10.25259","volume":"144","author":[{"given":"Vedantam","family":"Rajshekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-5-20241212","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1212\/01.wnl.0000249113.11824.64","article-title":"Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India","volume":"67","author":"Rajshekhar","year":"2006","journal-title":"Neurology"},{"key":"R2-5-20241212","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(89)91771-6","article-title":"Cysticercosis causing single, small CT lesions in Indian patients with seizures","volume":"1","author":"Chandy","year":"1989","journal-title":"Lancet"},{"key":"R3-5-20241212","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0404.1991.tb04996.x","article-title":"Etiology and management of single small CT lesions in patients with seizures: understanding a controversy","volume":"84","author":"Rajshekhar","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"R4-5-20241212","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4269\/ajtmh.1996.54.352","article-title":"Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme-linked immunosorbent assay","volume":"54","author":"Allan","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"R5-5-20241212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0019-557X.138638","article-title":"Prevalence and risk factors for Taenia solium taeniasis in Kaniyambadi block, Tamil Nadu, South India","volume":"58","author":"Mohan","year":"2014","journal-title":"Indian J Public Health"},{"key":"R6-5-20241212","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/pim.12291","article-title":"Monitoring the outcomes of interventions against Taenia solium: options and suggestions","volume":"38","author":"Lightowlers","year":"2016","journal-title":"Parasite Immunol"},{"key":"R7-5-20241212","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4269\/ajtmh.2009.81.433","article-title":"Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis","volume":"81","author":"Guezala","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"R8-5-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4269\/ajtmh.1999.60.199","article-title":"Development of a serologic assay to detect Taenia solium taeniasis","volume":"60","author":"Wilkins","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"R9-5-20241212","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/JCM.01172-07","article-title":"Nested PCR for specific diagnosis of Taenia solium taeniasis","volume":"46","author":"Mayta","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R10-5-20241212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF00626094","article-title":"Comparative study of CT and MRI in patients with seizures and a solitary cerebral cysticercus granuloma","volume":"38","author":"Rajshekhar","year":"1996","journal-title":"Neuroradiology"},{"key":"R11-5-20241212","first-page":"679","article-title":"Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences","volume":"21","author":"Govindappa","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"R12-5-20241212","first-page":"206","article-title":"Cisternal cysticercosis: a diagnostic problem \u2013 a short report","volume":"49","author":"Bannur","year":"2001","journal-title":"Neurol India"},{"key":"R13-5-20241212","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/159.1.50","article-title":"An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)","volume":"159","author":"Tsang","year":"1989","journal-title":"J Infect Dis"},{"key":"R14-5-20241212","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol"},{"key":"R15-5-20241212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.trstmh.2007.10.010","article-title":"Seroprevalence of Taenia solium antibodies in Vellore district, South India","volume":"102","author":"Prabhakaran","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R16-5-20241212","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jnnp.54.6.561-a","article-title":"Cysticercus immunoblot assay in Indian patients with single small enhancing CT lesions","volume":"54","author":"Rajshekhar","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-5-20241212","first-page":"177","article-title":"Serological studies using ELISA and EITB in patients with solitary cysticercus granuloma and seizures","volume":"2","author":"Rajshekhar","year":"1997","journal-title":"Neurol Infect Epidemiol"},{"key":"R18-5-20241212","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.trstmh.2003.12.006","article-title":"Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients","volume":"98","author":"Prabhakaran","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R19-5-20241212","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.trstmh.2006.10.001","article-title":"Conformation-sensitive immunoassays improve the serodiagnosis of solitary cysticercus granuloma in Indian patients","volume":"101","author":"Prabhakaran","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R20-5-20241212","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0035-9203(98)91069-0","article-title":"A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru","volume":"92","author":"Garcia","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R21-5-20241212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0035-9203(02)90095-7","article-title":"Taenia solium cysticercosis in a village in Northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen","volume":"96","author":"Erhart","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R22-5-20241212","first-page":"S41","article-title":"Drop in antigen levels following successful treatment of subarachnoid neurocysticercosis","volume":"73","author":"Zamora","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"R23-5-20241212","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.trstmh.2010.07.005","article-title":"Long-term clinical evaluation of asymptomatic subjects positive for circulating Taenia solium antigens","volume":"104","author":"Alexander","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R24-5-20241212","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4269\/ajtmh.2009.80.379","article-title":"Urine antigen detection for the diagnosis of human neurocysticercosis","volume":"80","author":"Castillo","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"R25-5-20241212","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.trstmh.2011.05.010","article-title":"Field evaluation of urine antigen detection for diagnosis of Taenia solium cysticercosis","volume":"105","author":"Mwape","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R26-5-20241212","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3171\/jns.1993.78.3.0402","article-title":"Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria","volume":"78","author":"Rajshekhar","year":"1993","journal-title":"J Neurosurg"},{"key":"R27-5-20241212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0404.1997.tb00243.x","article-title":"Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures","volume":"96","author":"Rajshekhar","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R28-5-20241212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.57.2.177","article-title":"Proposed diagnostic criteria for neurocysticercosis","volume":"57","author":"Del Brutto","year":"2001","journal-title":"Neurology"},{"key":"R29-5-20241212","first-page":"171","article-title":"Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients","volume":"52","author":"Garg","year":"2004","journal-title":"Neurol India"},{"key":"R30-5-20241212","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/499359","article-title":"Management of potential neurocysticercosis in patients with HIV infection","volume":"42","author":"Prasad","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R31-5-20241212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/2047773212Y.0000000025","article-title":"Diagnostic criteria for neurocysticercosis, revisited","volume":"106","author":"Del Brutto","year":"2012","journal-title":"Pathog Glob Health"},{"key":"R32-5-20241212","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garc\u00eda","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R33-5-20241212","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/01.wnl.0000238514.51747.3a","article-title":"Treatment of neurocysticercosis: current status and future research needs","volume":"67","author":"Nash","year":"2006","journal-title":"Neurology"},{"key":"R34-5-20241212","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/archinte.1995.00430180088010","article-title":"Is the course of neurocysticercosis modified by treatment with antihelminthic agents?","volume":"155","author":"Carpio","year":"1995","journal-title":"Arch Intern Med"},{"key":"R35-5-20241212","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/WNL.43.6.1238","article-title":"Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures","volume":"43","author":"Rajshekhar","year":"1993","journal-title":"Neurology"},{"key":"R36-5-20241212","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.44.7.1344","article-title":"Albendazole in single CT ring lesions in epilepsy","volume":"44","author":"Padma","year":"1994","journal-title":"Neurology"},{"key":"R37-5-20241212","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199808000-00007","article-title":"Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial","volume":"17","author":"Baranwal","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R38-5-20241212","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0035-9203(03)90075-7","article-title":"Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases","volume":"97","author":"Gogia","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R39-5-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(03)00211-7","article-title":"Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial","volume":"143","author":"Kalra","year":"2003","journal-title":"J Pediatr"},{"key":"R40-5-20241212","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/088307380401900503","article-title":"Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis","volume":"19","author":"Singhi","year":"2004","journal-title":"J Child Neurol"},{"key":"R41-5-20241212","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2007.128058","article-title":"Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy","volume":"79","author":"Thussu","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R42-5-20241212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7326\/0003-4819-145-1-200607040-00009","article-title":"Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel","volume":"145","author":"Del Brutto","year":"2006","journal-title":"Ann Intern Med"},{"key":"R43-5-20241212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1212\/WNL.0b013e31827b90a8","article-title":"Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis","volume":"80","author":"Otte","year":"2013","journal-title":"Neurology"},{"key":"R44-5-20241212","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0404.1998.tb01730.x","article-title":"Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma","volume":"98","author":"Rajshekhar","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"R45-5-20241212","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/WNL.0b013e31820202dc","article-title":"A diagnostic and therapeutic scheme for a solitary cysticercus granuloma","volume":"75","author":"Singh","year":"2010","journal-title":"Neurology"},{"key":"R46-5-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"R47-5-20241212","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"The effects of albendazole treatment on neurocysticercosis: a randomized controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R48-5-20241212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial","volume":"14","author":"Garcia","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R49-5-20241212","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.WNL.0000130471.19171.D8","article-title":"Seizure outcome in patients with a solitary cerebral cysticercus granuloma","volume":"62","author":"Rajshekhar","year":"2004","journal-title":"Neurology"},{"key":"R50-5-20241212","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.WNL.0000036320.69823.EA","article-title":"Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis","volume":"59","author":"Carpio","year":"2002","journal-title":"Neurology"},{"key":"R51-5-20241212","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.44.9.1706","article-title":"Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis","volume":"44","author":"Del Brutto","year":"1994","journal-title":"Neurology"},{"key":"R52-5-20241212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijsu.2009.12.006","article-title":"Surgical management of neurocysticercosis","volume":"8","author":"Rajshekhar","year":"2010","journal-title":"Int J Surg"},{"key":"R53-5-20241212","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1227\/00006123-199505000-00026","article-title":"An endoscopic approach to cysticercosis cysts of the posterior third ventricle","volume":"36","author":"Neal","year":"1995","journal-title":"Neurosurgery"},{"key":"R54-5-20241212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.2000.92.1.0014","article-title":"Endoscopic management of cysticercal cysts within the lateral and third ventricles","volume":"92","author":"Bergsneider","year":"2000","journal-title":"J Neurosurg"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201644030-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:58:15Z","timestamp":1751497095000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/neurocysticercosis-diagnostic-problems-current-therapeutic-strategies\/"}},"subtitle":["Diagnostic problems &amp; current therapeutic strategies"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.198686","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}